Keynote Presentation: Legal Certainty and Business Investment
11:30 - 12:30
Press Conference for Patented Innovation
Chaired by Marinda Wu, President-elect ACS & Sunny Wang, Secretary General of Tri-State CACS
Presentation (10 min for each presenter)
12:30 - 14:00
Lunch Break & Social Networking
Afternoon Plenary Session: Inventions and Patent Strategies
Panel Presentation on Comparisons in Patent Examination among EU, US, JP and CN:
Patent examination officials will present and discuss their respective country's standards for patentability, with a focus on inventive step (non-obviousness) and enablement, including data disclosure in regards to the breadth of claims that may be granted. The session will conclude with comparison of the similarities and differences in patentability standards among the countries.
Chaired by Xiangling Zeng, President of China Patent Agent (H.K.) Ltd.
Topic: IP Strategies and Practices for Pharmaceuticals in China
Speaker: Qinkui Zhang, Director General of the Pharmaceutical and Biological Invention Examination Department at SIPO, China
Speaker: Satoshi Moriyasu, Deputy Director General of 3rd Patent Examination Department of JPO, Japan
15:45 - 16:00
16:00 - 18:00
Panel Presentation of Patent Prosecution and IP Protection:
Senior patent attorneys from the US, Europe, Korea，and other Asian countries will present and discuss their patent application preparation and prosecution strategies to address the patentability standards of USPTO, EPO, KIPO, JPO, and SIPO with an emphasis on addressing the patentability standards in their home country/region.
Topic:New Trends/Implications of Patent Examination in Pharmaceutical Field from the Perspective of Recent Decisions by China Supreme People’s Court on Two Pharmaceutical Inventions
Speaker: Tina Hong Tai, Partner and VP, China Patent Agent (H.K.) Ltd., China
Dinner (Invited Guests Only)
Saturday, May 26, 2012
Morning Plenary Session: Invention, Externalization and IP Transfer
8:30 – 10:15
Panel Presentation on Invention, IP Transfer and Commercialization: Universities and academic research institutions are the primary centers of innovation in China. How to turn innovative ideas from these academic institutions into economic activities that create jobs and financial returns remains a challenge for China’s leaders in academia, government and industry. We have assembled an excellent panel from some of the world’s most prominent and successful organizations in technology transfer, who will share their valuable experience.
Chaired by Kening Li, General Counsel, Chinese Biopharmaceutical Association (CBA) China
Topic: Pioneer Drug Discovery in China
Speaker: Hualiang Jiang , Vice-Director of the Shanghai Institute of Materia Medica, CAS, PRC
Topic: From Labs to Market: University Technology Transfer in the U.S
Speaker: Beth Werner, Senior IP Manager, Wisconsin Alumni Research Foundation (WARF), USA
Topic: Winning Strategy for Technology Transfer and Alliances with Business Partners
Speaker: Gil Granot-Mayer, Adv. General Counsel, Yeda Research & Development Co. Ltd. Israel;
Topic: China Medical City: An Incubator for Research-Based Companies
Speaker: David Yinghao Sun, Deputy Director and Chief Technology Officer at China Medical City, PRC;
Topic:Creation and Management of Biotech and High-tech Ventures
Speaker: Tao Guo, Vice President, Medicinal Chemistry, WuXi AppTec, China
Speaker: Hua Yang, Chief Scientific Officer , Pharmaron, China
12:15 - 14:00
Lunch Break & Social Networking
Afternoon Plenary Session: Biological Development & Invention Enforcement
14:00 – 15:50
Panel Presentations on Biological Drug Development:
This panel will discuss new challenges to obtaining and enforcing patents on biotech inventions. The panel will touch on patentable subject matter; what biotech inventions should be patented; the obviousness standard as applied to biotech inventions; the need for sufficient patent term given long product development timelines; and the need for effective relief following successful patent enforcement.
Panel Presentations & Discussion on Patent Enforcement:
This panel will discuss recent developments in patent litigation in Europe and the US, including Hatch-Waxman litigation. The presentations will also cover patent enforcement and defensive strategies.
Chaired by Peter Dolan, Head of Asia Pacific Patent Support, Sanofi
Topic: Patent Enforcement, a Catalyst to State IP Strategy
Speaker: Xin Chen, Deputy Director, CCPIT, China
Dinner (Invited Guests Only)
Sunday, May 27, 2012
Morning Plenary Session: China Hot Topics
China Pharmaceutical Hot Topics: From drug pricing policies to practices, from pharmaceutical data protection to trademark issues, the leaders in these fields will give insightful presentations and reviews.
Chaired by Deshan Li , Vice-President of Unitalen Attorneys, China
Topic: China Drug Pricing Policies and Practices
Speaker: Linjia Weng , Director of National Development and Reform Commission, China
Topic: Pharmaceutical Data Protection
Speaker: Bing Chen, VP of Chinese Pharmaceutical Association, China
Topic: Drug’s Trademark Protection
Speaker: XinHua Wu, The State Administration for Industry & Commerce of China
10:30 – 10:45
10:45 – 11:45
Roundtable Discussion on Patent Procurement and Enforcement in China:
Panelists in this roundtable discussion are from the judiciary, SIPO, multinational pharma, domestic Chinese pharma, and private practice. The panel will have an interactive dialogue on hot issues in patent protection and enforcement in pharmaceutical and life sciences in China. The topics will include how to protect innovations via strong patents, how to effectively enforce patents, and what should be taken into consideration when making deals. Panel members will also provide suggestions and tips on pre-litigation preparation and litigation.
Chaired by Ningling Wang, Partner, Finnegan Henderson
Xia Lou, Judge, Supreme Court, China
Guiming Liu, Deputy Director of Chemical Group, SIPO, China